Open Access
Real-World Toxicity and Hospitalization Outcomes Following Immunotherapy for Malignant Pleural Mesothelioma
Cureus · 14.11.2026
DOI: 10.7759/cureus.119661 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 14.11.2026. Verfasst von Reshma David und 1 weiteren Autor:innen. Beteiligte Einrichtung: Acute Medicine, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, GBR. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
cancer immunotherapyhospitalizationmalignant pleural mesothelioma (mpm)overall survivalprogression-free survival (pfs)
Autor:innen und Institutionen
- Acute Medicine, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, GBR.
- Oncology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, GBR.
Zitieren
APA
David, R., & Khan, R. (2026). Real-World Toxicity and Hospitalization Outcomes Following Immunotherapy for Malignant Pleural Mesothelioma. Cureus. https://doi.org/10.7759/cureus.119661
Vancouver
David R, Khan R. Real-World Toxicity and Hospitalization Outcomes Following Immunotherapy for Malignant Pleural Mesothelioma. Cureus. 2026. doi:10.7759/cureus.119661
BibTeX
@article{David2026,
author = {David, Reshma and Khan, Rehmatullah},
title = {Real-World Toxicity and Hospitalization Outcomes Following Immunotherapy for Malignant Pleural Mesothelioma},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.119661}
}
EUVIMED